top of page

Q4 2025 Disruption Aristocrats: The world’s top disruptive stocks

The world’s top large-cap disruptors, updated quarterly by Disruption News

Date:

January

2026

Executive summary


Q4 2025 was a solid quarter for the Disruption Aristocrats index, our quarterly list of the world’s top disruptive stocks. The average Aristocrat gained +3.66%, outperforming the S&P 500 (2.46%) for another quarter in a row.


Performance leadership remained concentrated in AI stocks. Micron (MU +56.7%) led the group as memory pricing tightened alongside accelerating AI demand. Alphabet (GOOGL +27.8%) benefited from improving AI monetization across Search and Cloud, while Lam Research (LRCX +19.9%) and Applied Materials (AMAT +18.0%) gained as capital spending on advanced chip manufacturing remained resilient. The AI infrastructure buildout continues to be the market’s most durable megatrend


Health tech & biotech stocks also contributed meaningfully. Eli Lilly (LLY +30.2%) advanced as investor confidence in the long-term earnings power of its GLP-1 franchise remained strong. And United Therapeutics (UTHR +11.2%) benefited from steady execution across its core pulmonary business and continued progress in regenerative medicine initiatives.


By contrast, several mega-cap stocks Nvidia (NVDA -0.4%), Microsoft (MSFT −6.9%), Meta Platforms (META −8.0%), and Netflix (NFLX -20.4%) saw shares consolidate after strong multi-year runs. Investors weighed elevated expectations against near-term spending cycles and margin pressures.


The quarter also brought meaningful index changes, with three removals and three new additions according with our strict rule-based selection criteria.

 

Additions and removals


Removals:


  • Rambus (RMBS) – Market capitalization fell below the $10 billion minimum.

  • PTC (PTC) – No longer outperforms the S&P 500 on a five-year basis.

  • Netflix (NFLX) – No longer outperforms the S&P 500 on a five-year basis.


New additions:


  • Exelixis (EXEL)

  • Intuitive Surgical (ISRG)

  • Analog Devices (ADI)

 

Current Disruption Aristocrats (Q4 2025)

 

Nvidia (NVDA) – AI / Robotics

 

The backbone of global AI compute, spanning data centers, autonomous systems, and accelerated computing.


Latest: Nvidia remains the standard-setter for AI acceleration despite near-term consolidation. Demand visibility remains strong across hyperscalers, sovereign AI projects, and enterprise deployments, reinforcing Nvidia’s central role in AI infrastructure.


Q4 2025 performance: −0.40%

 

Alphabet (GOOGL) – AI / Cloud Infrastructure


Combines unmatched data scale with leading AI research.


Latest: AI integration across Search, Cloud, and productivity tools continues to drive engagement and monetization leverage.


Q4 2025 performance: +27.81%


Microsoft (MSFT) – AI / Cloud Infrastructure


Anchors global enterprise computing and AI deployment.


Latest: Copilot adoption continues to expand across enterprise workflows, reinforcing Microsoft’s platform dominance.

 

Q4 2025 performance: −6.94%


Broadcom (AVGO) – AI / Cloud Infrastructure


A diversified semiconductor and infrastructure software leader.


Latest: Broadcom’s exposure to custom silicon, networking, and enterprise software provides durable cash flows. VMware integration continues to expand its software moat.


Q4 2025 performance: +3.81%


Meta Platforms (META) – AI / Digital Media


Owns the world’s largest social platforms and invests heavily in AI.


Latest: AI-driven ad efficiency continues to improve, while long-term bets in mixed reality remain a drag on margins.


Q4 2025 performance: −7.98%


Eli Lilly (LLY) – Biotech & Health Tech


A pharmaceutical leader at the center of metabolic and neurological innovation.


Latest: Lilly’s GLP-1 franchise continues to reshape global healthcare economics. Pipeline depth beyond obesity and diabetes remains a key long-term driver.


Q4 2025 performance: +30.20%


Micron Technology (MU) – AI / Semiconductors


Supplies high-performance memory essential for AI workloads.


Latest: AI-driven memory demand continues to tighten supply, supporting pricing power across HBM and advanced DRAM.


Q4 2025 performance: +56.69%


Lam Research (LRCX) – AI / Semiconductors


Provides equipment essential to advanced wafer fabrication.


Latest: Lam benefits from sustained AI-related fab investments and increasing equipment intensity per wafer.


Q4 2025 performance: +19.88%


Applied Materials (AMAT) – AI / Clean Energy & Climate Tech


A materials engineering leader across advanced chips and sustainability.


Latest: Applied benefits from both AI semiconductor demand and long-term efficiency improvements in chip manufacturing.


Q4 2025 performance: +18.03%


Arista Networks (ANET) – AI / Cloud Infrastructure


Provides the high-speed networking fabric powering modern data centers.


Latest: Arista continues expanding its footprint inside AI-optimized data centers, benefiting from higher-bandwidth requirements and software-defined networking adoption, even as near-term spending cycles fluctuate.


Q4 2025 performance: −12.22%


KLA Corporation (KLAC) – AI / Semiconductors


The inspection and metrology leader enabling advanced chip manufacturing.


Latest: KLA remains mission-critical to leading-edge semiconductor nodes, benefiting from rising complexity and tighter process tolerances.


Q4 2025 performance: +7.64%


Cadence Design Systems (CDNS) – AI / Semiconductors


Provides the design software powering every advanced chip.


Latest: Cadence’s AI-assisted design tools deepen switching costs and strengthen its position alongside leading foundries.


Q4 2025 performance: −11.19%


Fortinet (FTNT) – Cybersecurity / AI


Delivers integrated cybersecurity at global scale.


Latest: Margin pressure weighed on shares, though Fortinet’s platform approach and recurring revenue base remain intact.


Q4 2025 performance: −6.77%


United Therapeutics (UTHR) – Biotech & Health Tech


A rare-disease specialist with a bold regenerative medicine roadmap.


Latest: Progress in organ manufacturing and continued execution in pulmonary therapies reinforce UTHR’s long-term innovation profile.


Q4 2025 performance: +11.20%


Analog Devices (ADI) – Semiconductors


A leader in high-performance analog and mixed-signal chips.


Latest: ADI’s exposure to industrial automation, energy systems, and AI-adjacent infrastructure supports durable margins.

 

Q4 2025 performance: +13.34%


Intuitive Surgical (ISRG) – Robotics & Health Tech


The global leader in robotic-assisted surgery.


Latest: Procedure growth, recurring instrument revenue, and expanding indications reinforce ISRG’s long-term leadership.


Q4 2025 performance: +29.29%


Ubiquiti (UI) – Connectivity & IoT


Builds high-margin networking hardware for global markets.


Latest: Operational discipline and loyal users support strong cash generation, though shares saw profit-taking.


Q4 2025 performance: −17.94%


Exelixis (EXEL) – Biotech & Health Tech


A focused oncology company with a durable commercial franchise.


Latest: Strong cash flows and pipeline optionality position Exelixis as a high-quality large-cap biotech compounder.


Q4 2025 performance: +6.38% 

 

How we select the Disruption Aristocrats


Each Aristocrat meets five quantitative and qualitative thresholds that separate durable disruptors from short-term performers:


  • Sustained Growth: Five-year average revenue growth ≥10%.

  • Investing in the Future: R&D spending ≥5% of revenue.

  • Wide Moat: EBITDA margins ≥30%.

  • Proven Leadership: Outperformed the S&P 500 over five years.

  • Large-Cap Stability: Market cap above $10 billion.


Together, these filters identify world's top disruptive stocks that consistently turn innovation into durable, long-term growth.


Why it matters


Quality disruptors tend to outperform the broader stock market. If you look at the best-performing stocks of the last decade – Nvidia, Apple, Google, Amazon, Microsoft, Meta – all have profited from disruption.


Companies on the Disruption Aristocrats list balance innovation with stability. They offer exposure to long-term megatrends without the volatility of early-stage stocks.

.

Methodology overview


Each quarter, we screen global large-caps across profitability, reinvestment, and growth metrics, verify financials from public filings, and publish any additions or removals with commentary.


Sources: Company filings, FactSet, Bloomberg, and Disruption News research.


Disclaimer: For educational purposes only. Not investment advice.

bottom of page